CELLO in the News

The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome

National Library of Medicine | August 2022

The quest to prevent MS — and understand other post-viral diseases

Springer Nature | March 2022

Phase 4 Trial Will Test if Ocrevus Can Prevent MS Onset in RIS Patients

Multiple Sclerosis News Today | May 2021

CELLO Study to Explore Early Treatment of Multiple Sclerosis

Yale School of Medicine | May 2021

The CELLO study was presented at the following national/international congresses:

American Council for Research and Treatment in MS

West Palm Beach, Florida | February 2022

European Council for Research and Treatment in MS

Digital Conference | October 2021